Home/Filings/4/0001209191-21-016886
4//SEC Filing

Hayashida Jon K. 4

Accession 0001209191-21-016886

CIK 0000718937other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:37 PM ET

Size

8.9 KB

Accession

0001209191-21-016886

Insider Transaction Report

Form 4
Period: 2021-03-01
Hayashida Jon K.
VP, Global Clinical, Medical
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-01$35.98/sh+16,000$575,68026,794 total
  • Sale

    Common Stock

    2021-03-01$105.43/sh16,000$1,686,88010,794 total
  • Exercise/Conversion

    Common Stock Options

    2021-03-0116,00012,026 total
    Exercise: $35.98From: 2020-03-14Exp: 2029-03-13Common Stock (16,000 underlying)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.86 to $106.19, inclusive.
  • [F2]The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2023.

Issuer

STAAR SURGICAL CO

CIK 0000718937

Entity typeother

Related Parties

1
  • filerCIK 0001781825

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:37 PM ET
Size
8.9 KB